Is antitachycardia pacing a safe and efficacious alternative to shocks for fast ventricular tachyarrhythmia treatment?

Nature Clinical Practice Cardiovascular Medicine

Volumn 2, Issue 2, 2005, Pages 68-69

  Wathen, M S ^b   Exner, Derek V ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE

Author keywords

Antitachycardia pacing; Implantable cardioverter defibrillators; Ventricular tachyarrhythmias

Indexed keywords

ANTIARRHYTHMIC AGENT;

AGED; CARDIOGENIC SHOCK; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; DIZZINESS; FEMALE; HEART ELECTROPHYSIOLOGY; HEART PACING; HEART PALPITATION; HEART RIGHT VENTRICLE; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MEDICAL RECORD; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK MANAGEMENT; SAFETY; SHORT SURVEY; STATISTICAL ANALYSIS; SYNCOPE; TREATMENT OUTCOME;

AGED; CARDIAC PACING, ARTIFICIAL; ELECTRIC COUNTERSHOCK; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; INCIDENCE; MALE; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SYNCOPE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 20344397166     PISSN: 17434297     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncpcardio0116     Document Type: Short Survey

References (5)

1. Josephson M and Wellens HJ (2004) Implantable defibrillators and sudden cardiac death. Circulation 109: 2685-2691
2. Exner DV et al. (2001) Primary prevention of sudden death with implantable defibrillator therapy in patients with cardiac disease: Can we afford to do it? (Can we afford not to?). Circulation 104: 1564-1570
3. Schron EB et al. (2002) Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation 105: 589-594
4. Schaumann A et al. (1998) Empirical versus tested antitachycardia pacing in implantable cardioverter defibrillators: a prospective study including 200 patients. Circulation 97: 66-74
5. Pacifico A et al. (1999) Prevention of implantable-defibrillator shocks by treatment with sotalol. d,l-Sotalol Implantable Cardioverter-Defibrillator Study Group. N Engl J Med 340: 1855-1862